SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615219-22-000140
Filing Date
2022-11-03
Accepted
2022-11-03 09:28:35
Documents
13
Period of Report
2022-11-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K flks-20221101.htm   iXBRL 8-K 35027
5 flks-20221101_g1.jpg GRAPHIC 26951
  Complete submission text file 0001615219-22-000140.txt   240374

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20221101.xsd EX-101.SCH 1930
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20221101_lab.xml EX-101.LAB 23984
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20221101_pre.xml EX-101.PRE 12633
7 EXTRACTED XBRL INSTANCE DOCUMENT flks-20221101_htm.xml XML 11339
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 221356522
SIC: 2834 Pharmaceutical Preparations